Updated on:2023-07-16

Marbaloxavir (Xofluza) is a Cap-dependent endonuclease inhibitor and the only approved single-dose oral medication for the treatment of influenza. It is also the first antiviral flu drug with a novel mechanism of action to be approved by the U.S. FDA in nearly 20 years. It has been approved in multiple countries, including the United States, Japan, and China.

Updated on:2023-07-16

Chiheal Pharma Factory two products, ornidazole injection (specifications: 3ml:0.5g, 6ml:1.0g) and tranexamic acid injection (specification: 2.5ml:0.25g), have lived up to expectations, achieving a remarkable success by both being selected in the eighth batch of the national centralized procurement bidding list! The success of these two products is a result of the careful preparation and strategic planning by the group’s leadership, culminating in this excellent achievement!